GB1300516A

GB1300516A – Pharmaceutical compositions with a vitamin a activity
– Google Patents

GB1300516A – Pharmaceutical compositions with a vitamin a activity
– Google Patents
Pharmaceutical compositions with a vitamin a activity

Info

Publication number
GB1300516A

GB1300516A
GB38977/71A
GB3897771A
GB1300516A
GB 1300516 A
GB1300516 A
GB 1300516A
GB 38977/71 A
GB38977/71 A
GB 38977/71A
GB 3897771 A
GB3897771 A
GB 3897771A
GB 1300516 A
GB1300516 A
GB 1300516A
Authority
GB
United Kingdom
Prior art keywords
vitamin
polyoxyethylene sorbitan
activity
pharmaceutical compositions
aug
Prior art date
1970-08-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired

Application number
GB38977/71A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Koninklijke Philips NV

Original Assignee
Philips Gloeilampenfabrieken NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1970-08-22
Filing date
1971-08-19
Publication date
1972-12-20

1971-08-19
Application filed by Philips Gloeilampenfabrieken NV
filed
Critical
Philips Gloeilampenfabrieken NV

1972-12-20
Publication of GB1300516A
publication
Critical
patent/GB1300516A/en

Status
Expired
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K9/00—Medicinal preparations characterised by special physical form

A61K9/0012—Galenical forms characterised by the site of application

A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K31/00—Medicinal preparations containing organic active ingredients

A61K31/33—Heterocyclic compounds

A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin

A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom

A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 

A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin

A61K31/355—Tocopherols, e.g. vitamin E

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient

A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides

A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient

A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Abstract

1300516 Vitamin compositions PHILIPS GLOEILAMPENFABRIEKEN NV 19 Aug 1971 [22 Aug 1970] 38977/71 Heading A5B A clear self-emulsifiable injection composition is prepared by mixing (a) vitamin A propionate, (b) a polyethylene glycol ester or a polyoxyethylene sorbitan ester of a C 16-18 fatty acid and (c) glyceryl triacetate. The emulsifier (b) may be polyethylene glycol palmitate, polyoxyethylene sorbitan oleate or polyoxyethylene sorbitan ricinoleate. The composition may also include crystalline vitamin D 2 and/or D 3 and/or vitamin E alcohol or acetate.

GB38977/71A
1970-08-22
1971-08-19
Pharmaceutical compositions with a vitamin a activity

Expired

GB1300516A
(en)

Applications Claiming Priority (1)

Application Number
Priority Date
Filing Date
Title

NL7012460A

NL7012460A
(en)

1970-08-22
1970-08-22

Publications (1)

Publication Number
Publication Date

GB1300516A
true

GB1300516A
(en)

1972-12-20

Family
ID=19810838
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

GB38977/71A
Expired

GB1300516A
(en)

1970-08-22
1971-08-19
Pharmaceutical compositions with a vitamin a activity

Country Status (9)

Country
Link

JP
(1)

JPS5525162B1
(en)

AU
(1)

AU465702B2
(en)

CA
(1)

CA962192A
(en)

DE
(1)

DE2138586C2
(en)

ES
(1)

ES394393A1
(en)

FR
(1)

FR2103451B1
(en)

GB
(1)

GB1300516A
(en)

NL
(1)

NL7012460A
(en)

ZA
(1)

ZA715471B
(en)

Cited By (3)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US4075333A
(en)

1975-02-14
1978-02-21
Hoffmann-La Roche, Inc.
Stable injectable vitamin compositions

US6432445B1
(en)

1999-05-28
2002-08-13
Novartis Ag
Pharmaceutical capsules comprising a cyclosporin

EP3223795A4
(en)

*

2014-11-25
2018-07-25
Kl-Kepong Oleomas Sdn Bhd
Formulation for effective tocotrienol delivery

Families Citing this family (1)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

JPS58208215A
(en)

*

1982-05-31
1983-12-03
Sato Seiyaku Kk
Oil-soluble composition containing fat-soluble vitamin

Family Cites Families (2)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

FR1392487A
(en)

*

1963-09-19
1965-03-19
Eastman Kodak Co

Vitamin preparation insoluble in anhydrous water and susceptible to dispersion in water

DE2019839A1
(en)

*

1969-04-28
1970-11-05
Ferrosan As

Stable, clear, water-dispersible or water-dilutable solution containing vitamin A and process for its preparation

1970

1970-08-22
NL
NL7012460A
patent/NL7012460A/xx
not_active
Application Discontinuation

1971

1971-08-02
DE
DE2138586A
patent/DE2138586C2/en
not_active
Expired

1971-08-16
ZA
ZA715471A
patent/ZA715471B/en
unknown

1971-08-19
GB
GB38977/71A
patent/GB1300516A/en
not_active
Expired

1971-08-19
CA
CA120,889A
patent/CA962192A/en
not_active
Expired

1971-08-20
ES
ES394393A
patent/ES394393A1/en
not_active
Expired

1971-08-20
JP
JP6306271A
patent/JPS5525162B1/ja
active
Pending

1971-08-20
AU
AU32567/71A
patent/AU465702B2/en
not_active
Expired

1971-08-20
FR
FR7130439A
patent/FR2103451B1/fr
not_active
Expired

Cited By (6)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US4075333A
(en)

1975-02-14
1978-02-21
Hoffmann-La Roche, Inc.
Stable injectable vitamin compositions

US6432445B1
(en)

1999-05-28
2002-08-13
Novartis Ag
Pharmaceutical capsules comprising a cyclosporin

US6767555B2
(en)

1999-05-28
2004-07-27
Novartis Ag
Pharmaceutical compositions

EP3223795A4
(en)

*

2014-11-25
2018-07-25
Kl-Kepong Oleomas Sdn Bhd
Formulation for effective tocotrienol delivery

US10478417B2
(en)

2014-11-25
2019-11-19
Kl-Kepong Oleomas Sdn Bhd
Formulation for effective tocotrienol delivery

US10493055B2
(en)

2014-11-25
2019-12-03
Kl-Kepong Oleomas Sdn Bhd
Formulation for effective tocotrienol delivery

Also Published As

Publication number
Publication date

DE2138586C2
(en)

1985-02-28

CA962192A
(en)

1975-02-04

DE2138586A1
(en)

1972-02-24

ZA715471B
(en)

1972-04-26

ES394393A1
(en)

1975-04-01

NL7012460A
(en)

1972-02-24

JPS5525162B1
(en)

1980-07-04

FR2103451A1
(en)

1972-04-14

FR2103451B1
(en)

1974-09-06

AU3256771A
(en)

1973-02-22

AU465702B2
(en)

1975-10-02

Similar Documents

Publication
Publication Date
Title

CA1007244A
(en)

1977-03-22

Alkyl esters of alkylthioalkanoic acid and compositions stabilized thereby

GB1300516A
(en)

1972-12-20

Pharmaceutical compositions with a vitamin a activity

ES379001A1
(en)

1972-08-01

Stable aqueous steroid phosphate solutions

GB1481411A
(en)

1977-07-27

Pharmaceutical compositions

GB1287602A
(en)

1972-09-06

4,6-DICHLORO-Delta<4.6>-OESTRADIENES

CA1016459A
(en)

1977-08-30

Pharmaceutical compositions containing mycophenolic acid and its salts

GB1261989A
(en)

1972-02-02

5-thiazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing the same

GB1126892A
(en)

1968-09-11

Medicinal preparations for the treatment of prostatic hypertrophy

GB1327560A
(en)

1973-08-22

Effervescent pharmaceutical preparations

AU472375B2
(en)

1976-05-20

Dialkylaminoalkyl esters of arylaliphatic acids and acid addition salts thereof

CA994044A
(en)

1976-07-27

Crotonic acid and maleic ester, vinyle acetate copolymeres

IL36067A0
(en)

1971-03-24

Novel 1h-2,1,4-benzothiadiazine-3-carbamic acid esters,their preparation and use for control of fungi and mites

CA945544A
(en)

1974-04-16

16-METHYLENE-9.beta., 10.alpha.-STEROID COMPOUNDS, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THE NOVEL COMPOUNDS AS ACTIVE INGREDIENTS, AND METHODS OF PRODUCING THE SAID COMPOUNDSAND PREPARATIONS

GB1237741A
(en)

1971-06-30

Improvements in fungicidal agents

CA773108A
(en)

1967-12-05

Novel spirolactones of the steroid series novel methods of producing said compounds and pharmaceutical preparations containing said compounds as active substances

IE34348B1
(en)

1975-04-16

Esters of rho-biphenylylacetic acid

IE34386B1
(en)

1975-04-30

Pharmaceutical compositions

GB1174362A
(en)

1969-12-17

Oral Medicants for Haemorrhoids.

GB1176721A
(en)

1970-01-07

0-Cyclopentenecarboxylic Acids and Process for their Manufacture

GB1238709A
(en)

1971-07-07

AU1534270A
(en)

1971-11-25

Novel aminoalcohol esters of triketo 3, 7, 12 cholanic acid and salts thereof

CA946374A
(en)

1974-04-30

17.beta.-HYDROXY-17.alpha.-(2'-METHALLYL)9.beta.,10.alpha.-ANDROSTA-1,4,6-TRIEN-3-ONE, METHODS OF PRODUCING THIS COMPOUND AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUND AS AN ACTIVE INGREDIENT

GB1189217A
(en)

1970-04-22

09-nor-Testosterone Phenoxyacetate and 6-Methyl Derivatives thereof

GB1103686A
(en)

1968-02-21

Pharmaceutical compositions, and the active ingredients thereof

AU4035768A
(en)

1970-01-15

NEW 18-METHYL-9b, a10:-STEROIDS OF THE ANDROSTANE SERIES, METHODS OF PRODUCING THE SAME, PHARMACEUTICAL PREPARATIONS CONTAINING SAID COMPOUNDS AS ACTIVE INGREDIENTS AND METHOD OF PRODUCING THE SAID PREPARATIONS

Legal Events

Date
Code
Title
Description

1973-05-02
PS
Patent sealed

1980-08-13
732
Registration of transactions, instruments or events in the register (sect. 32/1977)

1989-04-12
PCNP
Patent ceased through non-payment of renewal fee

Download PDF in English

None